Newstral
Article
bizjournals.com on 2017-06-09 14:00
Earnings up at Patheon ahead of acquisition by Thermo Fisher
Related news
- Thermo Fisher completes acquisition of Patheonbizjournals.com
- Thermo Fisher completes acquisition of Durham's Patheonbizjournals.com
- Thermo Fisher buying Patheon for $5.2 billiontriblive.com
- Thermo Fisher buys Durham's Patheon for $5.2Bbizjournals.com
- Thermo Fisher closes $17.4B acquisitionbizjournals.com
- Thermo Fisher moving ahead with second Grand Island expansionbizjournals.com
- Thermo Fisher moving ahead with second New York expansionbizjournals.com
- Thermo Fisher bids $5.2B for PatheonArkansas Online
- The Petri Dish: FDA fast-tracks Covid-19 drug, Thermo Fisher acquisitionbizjournals.com
- Thermo Fisher in talks to buy Patheon: BloombergReuters
- Thermo Fisher plans Chelmsford expansionbizjournals.com
- Thermo Fisher hands boost to Inchinnan plantThe Herald
- Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma servicesReuters
- MThermo Fisher to acquire Patheon in deal valued at $7.2 billion, including $2 billion net debtmarketwatch.com
- Thermo Fisher nixes $12.7B Qiagen acquisition after shareholders opt outbizjournals.com
- Thermo Fisher to buy Oregon company for $4.2Bbizjournals.com
- Thermo Fisher lands manufacturing deal for Covid-19 vaccine candidatebizjournals.com
- How a Greek immigrant started multinational giant Thermo Fisherbizjournals.com
- Family of Thermo Fisher founder gives $5M gift to MITbizjournals.com